260 related articles for article (PubMed ID: 30565238)
1. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.
Dotta L; Tassone L; Badolato R
Curr Mol Med; 2011 Jun; 11(4):317-25. PubMed ID: 21506920
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Immunodeficiency in WHIM Syndrome.
Majumdar S; Murphy PM
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577453
[TBL] [Abstract][Full Text] [Related]
5. Genetics on a WHIM.
Al Ustwani O; Kurzrock R; Wetzler M
Br J Haematol; 2014 Jan; 164(1):15-23. PubMed ID: 24111611
[TBL] [Abstract][Full Text] [Related]
6. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
Bachelerie F
Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
[TBL] [Abstract][Full Text] [Related]
7. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
Lagane B; Chow KY; Balabanian K; Levoye A; Harriague J; Planchenault T; Baleux F; Gunera-Saad N; Arenzana-Seisdedos F; Bachelerie F
Blood; 2008 Jul; 112(1):34-44. PubMed ID: 18436740
[TBL] [Abstract][Full Text] [Related]
9. Cxcr4-haploinsufficient bone marrow transplantation corrects leukopenia in an unconditioned WHIM syndrome model.
Gao JL; Yim E; Siwicki M; Yang A; Liu Q; Azani A; Owusu-Ansah A; McDermott DH; Murphy PM
J Clin Invest; 2018 Aug; 128(8):3312-3318. PubMed ID: 29715199
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
Hernandez PA; Gorlin RJ; Lukens JN; Taniuchi S; Bohinjec J; Francois F; Klotman ME; Diaz GA
Nat Genet; 2003 May; 34(1):70-4. PubMed ID: 12692554
[TBL] [Abstract][Full Text] [Related]
11. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients.
Tassone L; Moratto D; Vermi W; De Francesco M; Notarangelo LD; Porta F; Lougaris V; Facchetti F; Plebani A; Badolato R
Blood; 2010 Dec; 116(23):4870-3. PubMed ID: 20736454
[TBL] [Abstract][Full Text] [Related]
12. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
Balabanian K; Lagane B; Pablos JL; Laurent L; Planchenault T; Verola O; Lebbe C; Kerob D; Dupuy A; Hermine O; Nicolas JF; Latger-Cannard V; Bensoussan D; Bordigoni P; Baleux F; Le Deist F; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
Blood; 2005 Mar; 105(6):2449-57. PubMed ID: 15536153
[TBL] [Abstract][Full Text] [Related]
13. Recurrent CXCR4 sequence variation in a girl with WHIM syndrome.
Alapi K; Erdos M; Kovács G; Maródi L
Eur J Haematol; 2007 Jan; 78(1):86-8. PubMed ID: 17087743
[TBL] [Abstract][Full Text] [Related]
14. WHIM syndrome: congenital immune deficiency disease.
Kawai T; Malech HL
Curr Opin Hematol; 2009 Jan; 16(1):20-6. PubMed ID: 19057201
[TBL] [Abstract][Full Text] [Related]
15. Warts and all: human papillomavirus in primary immunodeficiencies.
Leiding JW; Holland SM
J Allergy Clin Immunol; 2012 Nov; 130(5):1030-48. PubMed ID: 23036745
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 signaling in health and disease.
Pozzobon T; Goldoni G; Viola A; Molon B
Immunol Lett; 2016 Sep; 177():6-15. PubMed ID: 27363619
[TBL] [Abstract][Full Text] [Related]
17. How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.
Badolato R; Donadieu J;
Blood; 2017 Dec; 130(23):2491-2498. PubMed ID: 29066537
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 mutations in WHIM syndrome: a misguided immune system?
Diaz GA
Immunol Rev; 2005 Feb; 203():235-43. PubMed ID: 15661033
[TBL] [Abstract][Full Text] [Related]
19. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
[TBL] [Abstract][Full Text] [Related]
20. Low-level Cxcr4-haploinsufficient HSC engraftment is sufficient to correct leukopenia in WHIM syndrome mice.
Gao JL; Owusu-Ansah A; Paun A; Beacht K; Yim E; Siwicki M; Yang A; Liu Q; McDermott DH; Murphy PM
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]